Zdrowie i gospodarka · 22/09/2010

FDA Requests Public Comment on Proposed Study on Direct-to-Consumer Prescription Drug Print Advertisements

The Food and Drug Administration (FDA) is seeking public input on a proposed study examining the effect of promotional offers in direct-to-consumer prescription drug print advertisements on consumer perceptions of product risks and benefits, as part of the Paperwork Reduction Act of 1995 requirements.